Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal
SHR Neuro Krebs Kardio Stoffw Microb Lipid

In situ detektion von Androgenrezeptor Spleißvarianten in Prostatakrebszellen

Projektleitung:
El-Heliebi Amin
Laufzeit:
01.01.2016-31.12.2016
Art der Forschung
Angewandte Forschung
Mitarbeiter*innen
El-Heliebi, Amin, Projektleiter*in
Beteiligte MUG-Organisationseinheiten
Lehrstuhl für Zellbiologie, Histologie und Embryologie
Gefördert durch
Franz-Lanyar-Stiftung, Graz, Österreich
Publizierte Projektergebnisse
> Technological advances in the analysis of liquid b... Fraunhofer Institute for Cell Therapy and Immunology IZI; SEP 3-5, 2018; Potsdam, GERMANY. 2018.
> Visualisation and quantification of AR-V7, AR-FL, ... International Symposium on Minimal Residual Cancer; MAY 3-5, 2018; Montpellier, FRANCE. 2018.
> Molecular biomarkers for cancer research using liq... International Biotech Innovation Days ; MAY 23-25, 2018; Senftenberg, GERMANY. 2018.
> Early detection of therapy resistance in prostate ... Nano World Cancer Day 2018 - Precision Medicine for People – Smart Biomarkers, Nanotechnologies and more; JAN 31, 2018; Vienna, AUSTRIA. 2018.
> Using liquid biopsies to guide treatment decisions... Diagnostics-4-Future Conference 2018; NOV 28, 2018; Konstanz, Germany. 2018.
> An in situ padlock probe approach to detect Andro... CRUK CI Symposium: Applications of in-situ hybridisation in research and disease at Cancer Research UK Cambridge Institute ; MAY 17-18, 2017; Cambridge, United Kingdom. 2017.
> A liquid biopsy to detect Androgen Receptor Varian... EACR Conference on Cancer Genomics; JUN 25-28,2016; Cambridge, United Kingdom. 2017.
© Med Uni Graz Impressum